Abstract
Targeting human T‐lymphotropic virus type 1‐infected cells with an anti‐C‐C chemokine receptor 4 antibody in T‐lymphotropic virus type 1‐associated myelopathy
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have